Piershale Financial Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-50
Closed -$2.99K 302
2022
Q4
$2.99K Buy
+50
New +$2.72K ﹤0.01% 223
2016
Q4
Sell
-171
Closed -$6K 53
2016
Q3
$6K Hold
171
﹤0.01% 109
2016
Q2
$5K Hold
171
﹤0.01% 107
2016
Q1
$5K Hold
171
﹤0.01% 101
2015
Q4
$5K Hold
171
﹤0.01% 146
2015
Q3
$5K Hold
171
﹤0.01% 93
2015
Q2
$6K Hold
171
﹤0.01% 84
2015
Q1
$6K Hold
171
﹤0.01% 91
2014
Q4
$5K Hold
171
﹤0.01% 117
2014
Q3
$5K Hold
171
﹤0.01% 103
2014
Q2
$5K Hold
171
﹤0.01% 116
2014
Q1
$5K Hold
171
0.01% 98
2013
Q4
$5K Hold
171
0.01% 84
2013
Q3
$5K Hold
171
﹤0.01% 86
2013
Q2
$4K Buy
+171
New +$3.86K 0.01% 72

Other funds holding EHC

Piershale Financial Group's EHC Position: Q1 2023 in Review

Piershale Financial Group sold out of Encompass Health (EHC) in Q1 2023, closing a stake of 50 shares — an estimated $2.99K sold.

Piershale Financial Group first reported a position in EHC in Q2 2013 and held it in 15 quarters. The position peaked at $6K in Q3 2016. 392 funds tracked by Wall St. Rank hold EHC as of Q1 2023.

  • Piershale Financial Group reported no remaining Encompass Health position as of Q1 2023 after selling out during the quarter.
  • Piershale Financial Group sold 50 Encompass Health shares in Q1 2023, an estimated $2.99K.
  • Piershale Financial Group first reported a position in Encompass Health in Q2 2013 and held it in 15 quarters.
  • Piershale Financial Group's Encompass Health position peaked at $6K in Q3 2016.
  • 392 funds tracked by Wall St. Rank held Encompass Health as of Q1 2023.

Based on Piershale Financial Group's 13F filing for Q1 2023, filed 12 Apr 2023.